<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-530
Date of Submission: 2024-09-03

This report was submitted by a Pharmacist from Dorsey, Thomas and Maynard Medical Center concerning patient ANON-PX-2685. The subject is an adult female with a significant medical history including migraines, atrial fibrillation, seasonal allergies. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Ibuprofen (NSAID) administered via the Oral route at a dosage of 94mg, initiated on 2024-08-26 for Pain and inflammation and discontinued on 2024-09-02; Warfarin (Anticoagulant) administered via the Oral route at a dosage of 358mg, initiated on 2024-08-26 for Thromboembolism prevention and discontinued on 2024-09-02.

On approximately 2024-08-30, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Dizziness, Nausea, Maculopapular Rash, Headache, Anaphylaxis. The Dizziness was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. The Nausea was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovering'. The Maculopapular Rash was classified as Moderate in severity. This necessitated clinical intervention. The current patient status regarding this symptom is 'Not Recovered'. The Headache was classified as Moderate in severity. This necessitated clinical intervention. The documented action was: Prescribed area and advised relationship. The current patient status regarding this symptom is 'Recovering'. The Anaphylaxis was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 9 was calculated, The assessment concluded the relationship was 'Highly Probable'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Identify popular simply seven check onto. Culture something season likely. Whether ball particular sense many.</data>
report_id: ADR-2024-530
report_date: '2024-09-03'
patient_details:
  patient_id: ANON-PX-2685
  gender: Female
  relevant_history:
  - migraines
  - atrial fibrillation
  - seasonal allergies
suspected_drugs:
- drug_name: Ibuprofen
  dosage: 94mg
  route_of_administration: Oral
  start_date: '2024-08-26'
  indication_for_use: Pain and inflammation
  drug_class: NSAID
  end_date: '2024-09-02'
- drug_name: Warfarin
  dosage: 358mg
  route_of_administration: Oral
  start_date: '2024-08-26'
  indication_for_use: Thromboembolism prevention
  drug_class: Anticoagulant
  end_date: '2024-09-02'
adverse_reactions:
- symptom_name: Dizziness
  onset_date: '2024-08-30'
  severity: Moderate
  outcome: Recovered
  intervention_required: false
- symptom_name: Nausea
  onset_date: '2024-08-30'
  severity: Moderate
  outcome: Recovering
  intervention_required: false
- symptom_name: Maculopapular Rash
  onset_date: '2024-08-30'
  severity: Moderate
  outcome: Not Recovered
  intervention_required: true
- symptom_name: Headache
  onset_date: '2024-08-30'
  severity: Moderate
  outcome: Recovering
  intervention_required: true
  intervention_details: Prescribed area and advised relationship.
- symptom_name: Anaphylaxis
  onset_date: '2024-08-30'
  severity: Severe
  outcome: Unknown
  intervention_required: false
causality_assessment:
  assessment_conclusion: Highly Probable
  dechallenge_rechallenge: Not applicable
  naranjo_score: 9
reporting_facility: Dorsey, Thomas and Maynard Medical Center
reporter_type: Pharmacist
notes: Identify popular simply seven check onto. Culture something season likely.
  Whether ball particular sense many.
